🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 15 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/06/2023 | 72,01 | 73,72 | 71,78 | 72,60 | +0,75% | 2,69% | 60.600 |
| 28/06/2023 | 71,81 | 72,46 | 71,16 | 72,06 | +0,50% | 1,81% | 69.800 |
| 27/06/2023 | 72,45 | 73,17 | 71,56 | 71,70 | -0,77% | 2,22% | 65.800 |
| 26/06/2023 | 72,87 | 74,22 | 72,14 | 72,26 | -1,14% | 2,85% | 67.700 |
| 23/06/2023 | 74,97 | 75,66 | 72,51 | 73,09 | -3,41% | 4,20% | 291.000 |
| 22/06/2023 | 76,49 | 76,80 | 75,18 | 75,67 | -1,55% | 2,12% | 95.400 |
| 21/06/2023 | 76,87 | 77,30 | 74,61 | 76,86 | -0,56% | 3,50% | 105.700 |
| 20/06/2023 | 77,79 | 78,00 | 76,03 | 77,29 | -0,95% | 2,53% | 71.500 |
| 16/06/2023 | 79,71 | 80,68 | 77,77 | 78,03 | -1,22% | 3,65% | 304.600 |
| 15/06/2023 | 77,82 | 79,69 | 76,16 | 78,99 | +1,27% | 4,54% | 120.500 |
| 14/06/2023 | 76,90 | 78,14 | 76,47 | 78,00 | +1,44% | 2,17% | 136.000 |
| 13/06/2023 | 74,51 | 77,05 | 74,20 | 76,89 | +3,85% | 3,82% | 128.400 |
| 12/06/2023 | 74,11 | 74,84 | 72,94 | 74,04 | +0,38% | 2,56% | 75.600 |
| 09/06/2023 | 74,50 | 74,87 | 73,40 | 73,76 | -0,70% | 1,97% | 115.000 |
| 08/06/2023 | 74,90 | 74,93 | 72,82 | 74,28 | -0,63% | 2,82% | 83.200 |
| 07/06/2023 | 72,87 | 75,02 | 72,49 | 74,75 | +3,10% | 3,47% | 108.800 |
| 06/06/2023 | 71,27 | 73,54 | 70,17 | 72,50 | +2,11% | 4,73% | 90.000 |
| 05/06/2023 | 74,78 | 74,78 | 70,41 | 71,00 | -5,72% | 5,84% | 90.600 |
| 02/06/2023 | 72,00 | 75,40 | 71,05 | 75,31 | +5,77% | 6,04% | 129.100 |
| 01/06/2023 | 70,04 | 71,56 | 69,40 | 71,20 | +1,60% | 3,08% | 103.300 |
| 31/05/2023 | 69,60 | 71,92 | 68,87 | 70,08 | +0,79% | 4,38% | 101.300 |
| 30/05/2023 | 72,03 | 72,28 | 68,97 | 69,53 | -3,60% | 4,60% | 92.900 |
| 26/05/2023 | 71,69 | 72,78 | 71,25 | 72,13 | +0,63% | 2,13% | 70.000 |
| 25/05/2023 | 74,43 | 75,10 | 71,36 | 71,68 | -3,90% | 5,02% | 96.800 |
| 24/05/2023 | 76,11 | 76,68 | 73,21 | 74,59 | -3,61% | 4,56% | 96.500 |
| 23/05/2023 | 75,47 | 78,73 | 75,47 | 77,38 | +2,71% | 4,32% | 161.500 |
| 22/05/2023 | 74,65 | 76,76 | 74,61 | 75,34 | +1,33% | 2,88% | 95.400 |
| 19/05/2023 | 77,00 | 77,68 | 73,56 | 74,35 | -3,32% | 5,35% | 108.700 |
| 18/05/2023 | 78,71 | 78,71 | 75,45 | 76,90 | -2,57% | 4,14% | 100.500 |
| 17/05/2023 | 77,14 | 79,92 | 75,12 | 78,93 | +2,32% | 6,22% | 146.400 |